Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: RFA vs. SBRT for Small HCC [Phase 3]
Phase 3 clinical trial comparing radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma is …
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama [Phase 2]
Phase 2 trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with bevacizumab and toripalimab for advanced hepatocellular…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial of pembrolizumab in advanced hepatocellular carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating bavituximab with sorafenib in advanced hepatocellular carcinoma (liver cancer) has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: PI-88 in Hepatocellular Carcinoma After Hepatectomy [Phase 2]
Phase 2 clinical trial update for PI-88 in hepatocellular carcinoma after hepatectomy has completed; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-11-12FDA Approved: SORAFENIB — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's original application for a generic sorafenib product, enabling a generic version of the cancer drug Sorafenib to be …
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC [Phase 2]
Phase 2 study evaluating safety and antitumoral efficacy of nivolumab after selective internal radiation therapy in hepatocellular carcinoma…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of acetazolamide combined with levamisole for hepatocellular carcinoma (HCC) is in progress…
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HBV-specific antigen peptide- and HepG2 lysate-activated dendritic cells combined with transarterial c…
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update for a cocktail therapy in hepatocellular carcinoma associated with hepatitis B.
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Clinical trial update for tivozanib in advanced or non-resectable hepatocellular carcinoma (HCC) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC [Phase 2]
Phase 2 clinical trial update evaluating TACE plus HAIC with oxaliplatin and raltitrexed for hepatocellular carcinoma (BCLC stage C).
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: DKN-01 Inhibition in Advanced Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for DKN-01 inhibition in hepatocellular carcinoma (advanced liver cancer).
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, and efficacy of cabozantinib in hepatocellular carcinoma patients with impaired live…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver [NA]
A terminated clinical trial assessing the effect of Y-90 therapy on non-target/background liver tissue in hepatocellular carcinoma and liver…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients [Phase 4]
Phase 4 trial update evaluating efficacy and safety of Drug Eluting Beads Transarterial Chemoembolization in Egyptian patients with hepatoce…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Survivorship Promotion In Reducing IGF-1 Trial [Phase 2]
Phase 2 trial evaluating survivorship promotion by reducing IGF-1 has completed, with results posted in 2020.
-
CLINICAL_TRIALS withdrawal · 2020-09-14Clinical Trial Update: HepATocellular Cancer Hcv Therapy Study [Phase 3]
Phase 3 trial for hepatocellular carcinoma/HCV therapy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC [Phase 2]
Phase 2 trial exploring the combination of sintilimab with stereotactic body radiotherapy in advanced metastatic hepatocellular carcinoma.
-
FDA approval · 2020-09-10FDA Approved: SORAFENIB TOSYLATE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved a generic sorafenib tosylate product from Mylan under an original application. Sorafenib is indicated for hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) [Phase 1]
Phase 1 trial update of avelumab plus axitinib in advanced hepatocellular carcinoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs [Phase 1, Phase 2]
Clinical trial update for autologous tumor-infiltrating lymphocytes (TILs) in high-risk recurrent primary hepatocellular carcinoma (PHASE 1/…
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer [Phase 2]
Phase 2 trial evaluating carrelizumab plus apatinib mesylate and radiotherapy for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial investigating the effect of colchicine for palliative management of hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer [Phase 1]
Phase 1 trial updating use of nivolumab with Yttrium-90 glass microspheres in advanced hepatocellular carcinoma; study completed with result…